Neuromuscular dysfunction acquired in critical illness: a systematic review

[1]  Lung.  Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome , 2009 .

[2]  M. Honavar,et al.  Patterns of neurophysiological abnormality in prolonged critical illness , 1998, Intensive Care Medicine.

[3]  H. Burchardi,et al.  Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis , 1997, Intensive Care Medicine.

[4]  G. Van den Berghe,et al.  Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. , 2007, American journal of respiratory and critical care medicine.

[5]  N. Latronico,et al.  Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study , 2007, Critical care.

[6]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[7]  V. Montori,et al.  The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Lefaucheur,et al.  Origin of ICU acquired paresis determined by direct muscle stimulation , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[10]  J. Finn,et al.  Long-term survival from intensive care: a review , 2005, Intensive Care Medicine.

[11]  N. Latronico,et al.  Neuromuscular sequelae of critical illness , 2005, Current opinion in critical care.

[12]  C. Bolton.  Neuromuscular manifestations of critical illness , 2005, Muscle & nerve.

[13]  F Bruyninckx,et al.  Insulin therapy protects the central and peripheral nervous system of intensive care patients , 2005, Neurology.

[14]  Michael N Diringer.  Improved outcome with aggressive treatment of hyperglycemia , 2005, Neurology.

[15]  S. Weber-Carstens,et al.  Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome* , 2005, Critical care medicine.

[16]  L. Dušek,et al.  Risk factors for critical illness polyneuromyopathy , 2005, Journal of Neurology.

[17]  G. Van den Berghe,et al.  Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality?* , 2005, Critical care medicine.

[18]  V Demicheli,et al.  Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review , 2005, The Lancet.

[19]  Karen J. Chan,et al.  Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. , 2005, American journal of respiratory and critical care medicine.

[20]  J. Garnacho-Montero,et al.  Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients* , 2005, Critical care medicine.

[21]  J. Willeit,et al.  Polyneuropathies in critically ill patients: A prospective evaluation , 1996, Intensive Care Medicine.

[22]  F. Leijten,et al.  Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator , 1996, Intensive Care Medicine.

[23]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[24]  Laurent Brochard,et al.  Does ICU-acquired paresis lengthen weaning from mechanical ventilation? , 2004, Intensive Care Medicine.

[25]  J. Garnacho-Montero,et al.  Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease , 2004, Intensive Care Medicine.

[26]  P. Vondracek,et al.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity , 2003, Intensive Care Medicine.

[27]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[28]  V. P. Misra,et al.  Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness* , 2003, Critical care medicine.

[29]  Catherine M. Lee,et al.  Neuromuscular sequelae of critical illness. , 2003, The New England journal of medicine.

[30]  Arthur S Slutsky,et al.  One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.

[31]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[32]  D. Angus,et al.  Surviving Intensive Care: a report from the 2002 Brussels Roundtable , 2003, Intensive Care Medicine.

[33]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[34]  Scott Lorin,et al.  Critical illness neuromuscular abnormalities. , 2002, Critical care clinics.

[35]  D. Lacomis,et al.  Critical illness neuromyopathies. , 2002, Advances in neurology.

[36]  L. Visser,et al.  Risk factors for the development of polyneuropathy and myopathy in critically ill patients , 2001, Critical care medicine.

[37]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[38]  J. Garnacho-Montero,et al.  Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients , 2001, Intensive Care Medicine.

[39]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[40]  K. Druschky,et al.  Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study , 2001, Intensive Care Medicine.

[41]  J. Kros,et al.  Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue , 2000, Journal of Neuroimmunology.

[42]  S. Hagl,et al.  Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. , 2000, The Thoracic and cardiovascular surgeon.

[43]  Paterson Rl,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[44]  J. Haas,et al.  Incidence and onset of critical illness polyneuropathy in patients with septic shock. , 2000, Netherlands Journal of Medicine.

[45]  U. Zifko.  Long‐term outcome of critical illness polyneuropathy , 2000, Muscle & nerve. Supplement.

[46]  E. Hund.  Myopathy in critically ill patients. , 1999, Critical care medicine.

[47]  F. Jardin,et al.  Improved prognosis of acute respiratory distress syndrome 15 years on , 1999, Intensive Care Medicine.

[48]  J. Lefaucheur,et al.  Acquired neuromuscular disorders in critically ill patients: a systematic review , 1998, Intensive Care Medicine.

[49]  T. Evans,et al.  Comparison of nose and face mask CPAP therapy for sleep apnoea , 1998, Thorax.

[50]  A. V. Van Cott,et al.  Acute myopathy after liver transplantation , 1998, Neurology.

[51]  S. Hagl,et al.  Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery? , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[52]  M. Rich,et al.  Direct muscle stimulation in acute quadriplegic myopathy , 1997, Muscle & nerve.

[53]  M. Rudis,et al.  Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. , 1996, Critical care medicine.

[54]  A. V. Van Cott,et al.  Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects , 1996, Annals of neurology.

[55]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[56]  D. Recupero,et al.  Critical illness myopathy and neuropathy , 1996, The Lancet.

[57]  M. Rich,et al.  Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.

[58]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[59]  F. Leijten,et al.  The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical Ventilation , 1995 .

[60]  W. Knaus.  The APACHE III Prognostic System , 1992 .

[61]  Y. Kupfer,et al.  Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide , 1992, Annals of Internal Medicine.

[62]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[63]  W. Sibbald,et al.  Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.

[64]  R. Goris,et al.  Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.

[65]  W. Sibbald,et al.  Polyneuropathy in critically ill patients. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[66]  I. MacFarlane,et al.  SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.

[67]  B Eiseman,et al.  Multiple organ failure. , 1977, Surgery, gynecology & obstetrics.

[68]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[69]  L. Ose.  L.D.L. AND TOTAL CHOLESTEROL IN CORD-BLOOD SCREENING FOR FAMILIAL HYPERCHOLESTEROLÆMIA , 1975, The Lancet.